Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated just now

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. A mouse model of metastasis-induced breast cancer cachexia with non-cachectic controls bearing isogenic primary tumors
    Y. Liang, Y.-Y. Kwon, M. Sabatier +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. Succinate Dehydrogenase in Lung Cancer: from Molecular Mechanisms to Clinical Implications.
    Yali Du, Lulu He, Yi Guo +2
    OncoTargets and therapyPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  3. Targeting cGMP pathways: the impact of vericiguat and high intensity interval training on mammary cancer progression in female mice
    Hamideh Bashiri, Afsaneh Soltany, Mohammad Amin Rajizadeh +1
    DARU Journal of Pharmaceutical SciencesPeer-reviewedLicence not statedFull textOncologyPMC
  4. Endothelial protein C receptor expression as a marker of reduced metastatic risk in primary melanoma
    Takayuki Fusumae, Takeru Funakoshi, Ikuko Hirai +5
    Melanoma ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  5. Financial navigation in gynecologic oncology: a qualitative study
    Anna Jo Bodurtha Smith, Daniel Carrera Mora, Caroline O'Brien +4
    Gynecologic Oncology ReportsPeer-reviewedCC BY-NC-NDFull textOncologyObstetrics, gynaecology & paediatricsDOAJEurope PMC
  6. Association between time-to-antibiotics and clinical outcomes in neutropenic fever after hematopoietic stem cell transplant
    Samuel L. Windham, Christopher A. Guidry, Anthony D. Sung +2
    Supportive Care in CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. Shining a Light on the Mechanisms of Drug Resistance to Anti-PD-1 Therapy in Non-small Cell Lung Cancer.
    Hongsheng Guo, Mengmeng Jiang, Hailian Zhang +2
    Human mutationPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  8. HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation.
    Tianqi Zhang, Cong Tan, Hui Sun +4
    Experimental hematology & oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  9. Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.
    Sithumini Sarathchandra, Jenny Nyqvist-Streng, Elin Sahlberg +6
    Breast cancer research and treatmentPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  10. Global cancer statistics among older adults in 2024 with projections to 2050: a multi-source population-based analysis.
    Jiahao Jiang, Maoqi Wang, Zhijun Chen +10
    Journal of hematology & oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  11. Immune checkpoints: cross-disease insights and clinical dilemmas.
    Yue Shu, Jia-Xin Zhao, Biao-Yu Guo +5
    Biomarker researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  12. CD73-targeted CAR-NK cell therapy displays potent antitumor activity and translational potential in relapsed/refractory lung adenocarcinoma.
    Qianqian Liu, Qifei Dong, Yimei Chen +10
    Biomarker researchPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  13. Spatial architecture of the tumor–stroma interface and transcriptional programs shape immunotherapy response in MSI-H gastrointestinal cancers
    Xueshuai Han, Kohei Yamashita, Melissa Pool Pizzi +25
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyDOAJPMC
  14. HIF-1α-mediated metabolic reprogramming in hypoxia-driven tumor metastasis
    Shulun Shao, Mengxin Wang, Renjian Xie +6
    Frontiers in Cell and Developmental BiologyPeer-reviewedCC BYFull textOncologyDOAJ
  15. Computed tomography-guided splanchnic nerve neurolysis outcomes by tumor site in unresectable pancreatic cancer: A single-center retrospective cohort study
    Hiroshi Baba, Hajime Takaki, Yasunari Yamada +5
    World journal of radiologyPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  16. Osteoimmuno-microbial feedback loops in medication-related osteonecrosis of the jaw: from dysbiosis to persistent structural osteonecrosis
    Bingyue Xu, Deqi Hu, Han Lu +4
    Journal of oral microbiologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  17. Aneuploidy profiling among different types of brain metastases reveals a colon cancer-specific chromosomal signature
    Aparajita Khan, Mengrui Zhang, Susan M. Grimes +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  18. A regenerative stem cell phenotype marked by ANXA1 defines aggressive colorectal cancer biology
    H. S. Rotte-Wettig, E. Domingo, G. Valbuena +23
    medRxivPreprintCC BYFull textOncologymedRxiv
  19. Diffusion-Weighted MRI of Breast Lesions: A Five-Case Series Demonstrating Imaging Patterns and Diagnostic Pitfalls.
    Preeti Yadav, Arindam Mukherjee, Riya Samanta
    CureusPeer-reviewedCC BYFull textMedical imaging & radiologyOncologyEurope PMCPMC
  20. Pancreatic Acinar Cell Carcinoma in a Patient with Familial Adenomatous Polyposis Who Achieved Long-Term Survival after Repeated Resection of Liver Metastases: A Case Report.
    Ayano Takahashi, Toshiro Ogura, Naganori Yamada +4
    Surgical case reportsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  21. Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder
    Maria Mappoura, Yara Hajj Younes, Sisi Wang +19
    EJHaemPeer-reviewedCC BYFull textOncologyEurope PMCEurope PMCPMC
  22. Randomized, Controlled, Crossover Trial Comparing Immediate Effects of Components of Complex Decongestive Therapy in Lower-limb Lymphedema Patients.
    Asako Oka, Tetsuya Tsuji, Kiriko Abe +8
    Progress in rehabilitation medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  23. Investigating Risk Factors for Delayed Melanoma Recurrence Beyond 5 Years Post-Primary Tumor Diagnosis.
    Kaspar Itin, Rebecca Lapides, Soumya Paria +16
    Cancer medicinePeer-reviewedCC BYFull textOncologyEurope PMCDOAJPMC
  24. Phase 1 Study of Safety and PK With A Combination of Omeprazole and Trimetazidine for Fatty Acid Oxidation Inhibition in Patients With Advanced Solid Tumors.
    Wonyoung Choi, Jung W Chun, Sung H Sim +9
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  25. Virtual Social Interaction and Psychological Capital in Chemotherapy Patients: A Randomized Controlled Trial.
    Masome Rafat, Ali Pourhabib, Amaneh Mahmoudian +3
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC